These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 19376433

  • 1. Prevention of diabetic retinopathy.
    Einarsdóttir AB, Stefánsson E.
    Lancet; 2009 Apr 18; 373(9672):1316-8. PubMed ID: 19376433
    [No Abstract] [Full Text] [Related]

  • 2. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
    Haritoglou C, Gerss J, Sauerland C, Kampik A, Ulbig MW, CALDIRET study group.
    Lancet; 2009 Apr 18; 373(9672):1364-71. PubMed ID: 19376452
    [Abstract] [Full Text] [Related]

  • 3. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
    Ribeiro ML, Seres AI, Carneiro AM, Stur M, Zourdani A, Caillon P, Cunha-Vaz JG, DX-Retinopathy Study Group.
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec 18; 244(12):1591-600. PubMed ID: 16763797
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic and therapeutic challenges.
    Dinç UA, Yenerel NM, Görgün E, Yetik H, Kokame GT, Lim JI.
    Retina; 2009 Feb 18; 29(2):275-9. PubMed ID: 18827730
    [No Abstract] [Full Text] [Related]

  • 5. Calcium dobesilate versus placebo in the treatment of diabetic retinopathy: a double-blind cross-over study.
    Binkhorst PG, Van Bijsterveld OP.
    Curr Ther Res Clin Exp; 1976 Sep 18; 20(3):283-8. PubMed ID: 822986
    [No Abstract] [Full Text] [Related]

  • 6. [The plasma levels of endothelin in diabetic retinopathy and their changes after treatment with doxium].
    Zhong H, Guo L.
    Hunan Yi Ke Da Xue Xue Bao; 1997 Sep 18; 22(1):56-8. PubMed ID: 9868029
    [Abstract] [Full Text] [Related]

  • 7. The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial.
    Larsen HW, Sander E, Hoppe R.
    Diabetologia; 1977 Apr 18; 13(2):105-9. PubMed ID: 323093
    [Abstract] [Full Text] [Related]

  • 8. Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy.
    Berthet P, Farine JC, Barras JP.
    Int J Clin Pract; 1999 Dec 18; 53(8):631-6. PubMed ID: 10692760
    [Abstract] [Full Text] [Related]

  • 9. The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.
    Stamper RL, Smith ME, Aronson SB, Cavender JC, Cleasby GW, Fung WE, Becker B.
    Ophthalmology; 1978 Jun 18; 85(6):594-606. PubMed ID: 353623
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of the diabetic retinopathy with doxium-clofibrate (author's transl)].
    Freyler H, Egerer I.
    Klin Monbl Augenheilkd; 1976 Mar 18; 168(3):377-86. PubMed ID: 787642
    [Abstract] [Full Text] [Related]

  • 11. Calcium hydroxybenesulfonate improves vascular proliferation in patients with diabetic retinopathy via reducing VEGF, CAM-1 and MMP-9.
    Yao L, Li Y, Zhao Z.
    Minerva Med; 2021 Oct 18; 112(5):668-670. PubMed ID: 32255310
    [No Abstract] [Full Text] [Related]

  • 12. Calcium dobesilate in diabetic retinopathy. A retrospective controlled study.
    Adank C, Koerner F.
    Ophthalmologica; 1985 Oct 18; 190(2):102-11. PubMed ID: 3982791
    [Abstract] [Full Text] [Related]

  • 13. [Treatment in diabetic maculopathy].
    Irimia A, Ignat F.
    Oftalmologia; 2011 Oct 18; 55(4):20-8. PubMed ID: 22642132
    [No Abstract] [Full Text] [Related]

  • 14. Microvascular protection with calcium dobesilate (Doxium) in diabetic retinopathy.
    Freyler H.
    Ophthalmologica; 1974 Oct 18; 168(5):400-16. PubMed ID: 4598805
    [No Abstract] [Full Text] [Related]

  • 15. Calcium dobesilate attenuates vascular injury and the progression of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Padilla E, Ganado P, Sanz M, Zeini M, Ruiz E, Triviño A, Ramírez AI, Salazar JJ, Ramírez JM, Rojas B, Hoz Rd, Tejerina T.
    Diabetes Metab Res Rev; 2005 Oct 18; 21(2):132-42. PubMed ID: 15386814
    [Abstract] [Full Text] [Related]

  • 16. [Early initiation recommended: calcium dobesilate in diabetic retinopathy].
    Ophthalmologe; 1998 Jun 18; 95(6 Suppl):1-4. PubMed ID: 9702079
    [No Abstract] [Full Text] [Related]

  • 17. Treatment outcome in diabetic macular edema.
    Saxena S.
    Indian J Ophthalmol; 1997 Dec 18; 45(4):260-1. PubMed ID: 9567027
    [No Abstract] [Full Text] [Related]

  • 18. Influence of calcium dobesilate (Doxium) on blood viscosity and coagulation parameters in diabetic retinopathy.
    Vinazzer H, Hachen HJ.
    Vasa; 1987 Dec 18; 16(2):190-2. PubMed ID: 3300085
    [No Abstract] [Full Text] [Related]

  • 19. Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy.
    Chae JB, Joe SG, Yang SJ, Lee JY, Sung KR, Kim JY, Kim JG, Yoon YH.
    Retina; 2014 Jan 18; 34(1):149-56. PubMed ID: 23807186
    [Abstract] [Full Text] [Related]

  • 20. [Results of the use of calcium dobesilate in diabetic retinopathy].
    Trutneva KV, Katsnel'son LA, Dudnikova LK, Balishanskaia TI.
    Vestn Oftalmol; 1978 Jan 18; (2):68-71. PubMed ID: 653927
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.